[ Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, Ozempic and Wegovy. On Wednesday, Sanders penned a letter to Novo Nordisk’s chief executive officer, Lars Fruergaard Jørgensen, notifying him … Read more
[ The weight loss medication Zepbound has gone into shortage just months after it was approved by the Food and Drug Administration (FDA), with its manufacturer Eli Lilly blaming the situation on high demand. As of this week, most tirzepatide injections (sold commercially as Mounjaro and Zepbound) have limited availability, according to the FDA’s shortage … Read more
[ Tonight on SNL, Poor Things star Ramy Youssef appeared as part of a commercial highlighting an exciting new product called Ozempic for Ramadan. After getting his kids ready for school, Youssef tells the viewer, “You know, fasting for Ramadan used to be easy, but the last few years of work and a growing family, … Read more
[ Semaglutide, a diabetes and obesity treatment that has grown in popularity in recent years, can be associated with a lower risk of suicidal ideation compared to other medications, according to a recent analysis. The study, funded by the National Institutes of Health (NIH), found that semaglutide was associated with a 49 to 73 percent … Read more
[ Data from poison control centers from around the country show a large increase in calls in connection with a weight-loss and diabetes drug. America’s Poison Centers reports around 3,000 calls in relation to semaglutide — an anti-diabetic medication — between January and November of this year, according to CNN. That is a rise of … Read more
